Responsiveness of Various Symptoms of Vascular Disorders to Calcium Antagonists

Verhaegen, H.; Reyntjens, A.; Horig, C.; P�tsch, W.
July 1979
Angiology;Jul1979, Vol. 30 Issue 7, p447
Academic Journal
Focuses on responsiveness of various symptoms of vascular disorders to calcium antagonists. Peripheral arterial disorders; Peripheral venous disorders; Treatment with cinnarizine and flunarizine.


Related Articles

  • Calcium channel blocking agents and the heart. Kenny, John // British Medical Journal (Clinical Research Edition);10/26/1985, Vol. 291 Issue 6503, p1150 

    Examines the therapeutic importance of the calcium channel blocking agents for cardiovascular disease. Characteristics of calcium channel blocking agents; Adverse effects of the treatment; Factors affecting the unwanted effects of the treatment.

  • Case-control study, meta-analysis, and bouillabaisse: Putting the calcium antagonist scare into... Messerli, Franz H. // Annals of Internal Medicine;12/1/95, Vol. 123 Issue 11, p888 

    Editorial. Discusses the wisdom of using calcium antagonists in treating cardiovascular ailments. Two sources of panic over the use of calcium antagonists in cardiovascular medicine; Description of the case-control study of Psaty and colleagues; Two possible sources of bias; Several...

  • A Global Research Imperative Diseases of the Heart.  // Countdown;Spring2003, Vol. 24 Issue 1, p16 

    Discusses the complications associated with diabetes. Two types of complications; Prevalence of diabetics at risk for macrovascular complications in the U.S.; Need to address the unique issues related to cardiovascular complications in type 1 diabetes; Chemical pathways that are implicated in...

  • Plasminogen Activator System and Vascular Disease. Nicholl, Suzanne M.; Roztocil, Elisa; Davies, Mark G. // Current Vascular Pharmacology;Apr2006, Vol. 4 Issue 2, p101 

    Vascular diseases, such as atherosclerosis, thromboembolic disorders and stroke, in addition to surgical procedures such as restenosis, all share the plasminogen activator system as a central component in the pathogenesis of vascular injury. Since the development of plasminogen deficient mice...

  • Inter-Relationships of microalbuminuria with the other surrogates of the atherosclerotic cardiovascular disease in hypertensive subjects. Tsioufis, Costas; Dimitriadis, Kyriakos; Antoniadis, Dimitris; Stefanadis, Christodoulos; Kallikazaros, Ioannis // American Journal of Hypertension;May2004, Vol. 17 Issue 5, p470 

    Clinical and epidemiologic data have demonstrated that microalbuminuria (MA) may legitimately be an integrated marker of cardiovascular risk in nondiabetic hypertensive patients. The relation of augmented urinary albumin excretion rate (UAER) with the other surrogates of the atherosclerotic...

  • Clinical Clips. Lobuono, Charlotte // Patient Care;10/15/2000, Vol. 34 Issue 19, p134 

    Presents summaries of medical research as of October 15, 2000. Use of colonoscopy for primary cancer screening; Effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality.

  • Combination therapy for hypertension.  // Neurology Alert;Feb2009 Pharmacology Watch, p1 

    The article discusses research on combination therapy for hypertension. It references a study by A. V. Chobanian in the 2008 issue of the "New England Journal of Medicine." The study, which administered either benazepril plus amlodipine or benazepril plus hydrochlorothiazide to participants,...

  • Pulmonary Vascular Disease in Children with Congenital Cardiovascular Malformations. Folger Jr., Gordon M. // Angiology;Dec1983, Vol. 34 Issue 12, p784 

    A detailed clinical analysis of 16 patients with various forms of congenital cardiac malformations with the potential for large left-to-right shunts who developed extreme pulmonary hypertension in infant y and early childhood has been carried out. The study plan was to include only patients with...

  • Vasoconstriction During Acute Hypervolemic Hemodilution in Hypertensive Patients is Not Prevented by Calcium Blockade. Wysocki, Marian; Andersson, Ove K.; Persson, Bengt; Bagge, Ulf // Angiology;Jan1998, Vol. 49 Issue 1, p41 

    The reduction of blood viscosity by moderate acute hypervolemic hemodilution in untreated hypertensives can be associated with a secondary vasoconstriction. The aim of this study was to examine whether a vasodilating therapy prevents this hemodynamic reaction. Twelve hypertensive patients (WHO...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics